Ann: Zoono Develops New Nasal Spray Product, page-6

I recall a couple of years ago there was talk of developing a nasal spray product and it was being tested at Auckland University.

Obviously that has exceeded expectations and this is the next step in development. Douglas have the pharmaceutical know-how to develop, run clinical trials and commercialise. Zoono couldn't do it alone but sounds like their IP is central to efficacy.

This is huge!

Antibiotics are increasingly problematic and most nasal sprays can only be used for a short time as they can complicate a condition further if overused.

Capital will be surely be needed to take it to market. I would say it will take a while but I'm much happier holding my shares now and waiting it out.

Good work team!

Interested to see what else the 'zoono molecule' can be used for...